Please join us virtually for a panel discussion on the science and application of biomarker testing, how biomarkers have advanced treatment for so many patients and the critical need to make testing more accessible and ultimately drive improved patient outcomes and health care equity for Oregonians and Washingtonians.
Following the panel, experience an exclusive virtual behind-the-scenes tour of Genentech’s 130,000-square-foot Individualized Therapies facility – the new $175-million investment located in Hillsboro, Oregon.
· Tzvia Bader, CEO and Co-founder of TrialJectory
· Dr. Chris Corless, M.D., Ph.D, Executive Director and Chief Medical Officer, Knight Diagnostic Laboratories and Professor of Pathology, OHSU
· Dr. Rachel Sanborn, M.D., Medical Director, Thoracic Oncology Program and Phase I Clinical Trials Program, Earle A. Chiles Research Inst., Providence Cancer Institute
Moderator: J.B. Smith, Genentech Biomarker Account Executive